PYC Therapeutics hit FDA milestone

24/05/2024 - 11:30

Bookmark

Save articles for future reference.

Perth biotech company PYC Therapeutics has hit a major milestone in the development of a first-in-class drug to treat a rare eye disease, recently receiving orphan drug designation from the US FDA.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options